Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to $118.7 million.

  • Acadia Healthcare Company's Cash & Equivalents rose 4449.21% to $118.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.7 million, marking a year-over-year increase of 4449.21%. This contributed to the annual value of $76.3 million for FY2024, which is 2375.07% down from last year.
  • Acadia Healthcare Company's Cash & Equivalents amounted to $118.7 million in Q3 2025, which was up 4449.21% from $131.4 million recorded in Q2 2025.
  • In the past 5 years, Acadia Healthcare Company's Cash & Equivalents registered a high of $196.3 million during Q3 2021, and its lowest value of $63.8 million during Q1 2023.
  • In the last 5 years, Acadia Healthcare Company's Cash & Equivalents had a median value of $100.1 million in 2023 and averaged $115.0 million.
  • Data for Acadia Healthcare Company's Cash & Equivalents shows a peak YoY increase of 12087.18% (in 2021) and a maximum YoY decrease of 6466.49% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's Cash & Equivalents stood at $133.8 million in 2021, then decreased by 27.03% to $97.6 million in 2022, then grew by 2.48% to $100.1 million in 2023, then dropped by 23.75% to $76.3 million in 2024, then skyrocketed by 55.55% to $118.7 million in 2025.
  • Its Cash & Equivalents was $118.7 million in Q3 2025, compared to $131.4 million in Q2 2025 and $91.2 million in Q1 2025.